Hospital pharmacies worry the president’s buy-American executive order could disrupt the very supply chain that it intends to secure by giving the federal government first dibs on domestically made drugs and ingredients that are part of existing private supply chains, American Society of Health-System Pharmacists Vice President of Government Relations Tom Kraus said. However, the disruptions would likely be minor because the executive order applies to about 2% to 3% of drugs in the U.S. market, according to a spokesperson...